Recent Updates
Recently added Catalysts
MMED Positive Sentiment

MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Key Takeaway: MiniMed will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026. The management will engage in a fireside chat, which will be accessible via a live webcast. MiniMed continues to innovate in diabetes technology, providing comprehensive solutions for diabetes management.
Price reaction · baseline $11.87 (2026-05-22 close) · hit after-hours · 1 other MMED headline(s) in the window, move may be shared
day 0 close
-5.8%
day 1 · peak
-9%
day 3
+1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • MiniMed is recognized as a leader in diabetes technology.
  • The company is actively engaging with investors at a prominent healthcare conference.
  • MiniMed's integrated ecosystem supports diabetes management effectively.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~21 mo
Low dilution risk
Lead asset
Aventis HOE21PH U400
Phase 3 · Type 1 Diabetes

Full Press Release Details

NORTHRIDGE, Calif.,May 26, 2026/PRNewswire/ -- MiniMed (Nasdaq:MMED), a global leader in diabetes technology, today announced that management will participate in a fireside chat at the upcoming Goldman Sachs 47thAnnual Global Healthcare Conference.
The fireside chat will take place on Monday, June 8, 2026, at 11:20 a.m. EDT.
A live webcast and replay will be accessible on the MiniMed Investor Relations website:investors.minimed.com/events.
About MiniMedMiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we've pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.
Any forward-looking statements are subject to risks and uncertainties such as those described in MiniMed's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Frequently Asked Questions

When will MiniMed participate in the conference?

MiniMed will participate in the conference on June 8, 2026.

How can I access the conference webcast?

The webcast will be available on MiniMed's Investor Relations website.

What is MiniMed known for?

MiniMed is a global leader in diabetes technology and insulin delivery.

What type of event is the Goldman Sachs conference?

It is a global healthcare conference featuring various industry discussions.

Last updated: May 26, 2026